A multicomponent food supplement with bromelain, escin, and selenium in patients with urological post-surgical complaints

S.E. Aragona, M. Zanoni, O. Sedigh, G. Savoca, G. Ciprandi, the Urosurvey Study

Article ID: 5437
Vol 36, Issue 2S2, 2022
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.202236.2S2.14
Received: 9 May 2022; Accepted: 9 May 2022; Available online: 9 May 2022; Issue release: 9 May 2022

Abstract

Urological surgery is common at any age. The most common surgical procedures include urological surgery, endoscopy, genitals surgery, and cystoscopic procedures. Broser® is a food supplement containing bromelain, escin, and selenium. Its efficacy has been positively tested in patients with otorhinolaryngological disorders. Therefore, the present clinical experience investigated the efficacy and safety of this product in patients undergoing urological surgery and treated with standard therapy. The add-on Broser® course lasted 2 weeks. The oral nutraceutical was taken following the specific indications, such as two tablets/daily. Patients were visited at baseline (T0) and after the treatment (T1). Patients in Group A had to take Broser® one tablet b.i.d. per 20 days. Evaluation parameters were the following signs and symptoms: pain, functional powerlessness, fever, oedema, malaise, dysuria, and infection severity. Globally, 697 patients participated in this clinical experience. The median age was 58 years. The food supplement significantly reduced the symptom severity and the incidence of symptoms. In conclusion, the present clinical experience demonstrated that the add-on therapy with Broser® significantly reduced the severity and incidence of symptoms consequent to urological surgery. Therefore, this food supplement could be fruitfully used in clinical practice.


Keywords

urological surgery;bromelain;escin;selenium;real-life study


References

Supporting Agencies



Copyright (c) 2022 S.E. Aragona, M. Zanoni, O. Sedigh, G. Savoca, G. Ciprandi, the Urosurvey Study Group




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).